LEWIS HAY III
CIK 1182705 · Exec Chairman · last filed 2026-05-15
LEWIS HAY III is an Exec Chairman who has filed 124 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for ELV, was dated May 15, 2026. Across all open-market trades the lifetime net is −$77.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $182.2M across reported positions. 88 SEC filings were submitted jointly with HARRIS CORP /DE/.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$182.15M
8
124
-$77.39M
Filer Profile
700 UNIVERSE BLVD
JUNO BEACH, FL 33408
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELV | Director | 12,070 | $418.72 | $5.05M | $0 | 4 | 2026-05-15 |
| LHX | Director | 21,497 | $245.54 | $5.28M | $1.99M | 14 | 2026-05-12 |
| Elevance Health, Inc. (ANTM) Delisted | Director | 10,061 | $482.58 | $4.86M | $0 | 5 | 2022-05-20 |
| COF | Director | 46,996 | $208.30 | $9.79M | -$3.50M | 14 | 2018-07-25 |
| ANTX | Director | 6,923 | $5.41 | $37.5K | $0 | 3 | 2017-05-22 |
| Elevance Health, Inc. (WLP) Delisted | Director | 1,867 | — | — | $0 | 1 | 2013-07-02 |
| NEE | Exec Chairman | 1,968,088 | $82.31 | $161.99M | -$63.13M | 12 | 2013-03-18 |
| NEXTERA ENERGY INC (FPL) Delisted | Chairman & CEO | 333,276 | $7.76 | $2.59M | -$12.75M | 15 | 2010-05-03 |
Recent Filings
124 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-15 | ELV | Grant (A) | +563 | $0 | EDGAR |
| 2026-05-12 | LHX | Grant (A) | +661 | $0 | EDGAR |
| 2025-05-16 | ELV | Grant (A) | +601 | $0 | EDGAR |
| 2025-04-22 | LHX | Grant (A) | +887 | $0 | EDGAR |
| 2024-05-17 | ELV | Grant (A) | +388 | $0 | EDGAR |
| 2024-04-23 | LHX | Grant (A) | +924 | $0 | EDGAR |
| 2023-05-12 | ELV | Grant (A) | +457 | $0 | EDGAR |
| 2023-04-25 | LHX | Mixed | +1,540 | $0 | EDGAR |
| 2022-05-20 | Elevance Health, Inc. (ANTM) Delisted | Grant (A) | +440 | $0 | EDGAR |
| 2022-04-26 | LHX | Mixed | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.